Copyright Reports & Markets. All rights reserved.

Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Overview

      • 1.1 Product Overview and Scope of T Cell Surface Glycoprotein CD3 Epsilon Chain
      • 1.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Segment by Type
        • 1.2.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 ND-007
        • 1.2.3 Foralumab
        • 1.2.4 Coltelizumab
        • 1.2.5 AVA-002
        • 1.2.6 Others
      • 1.3 T Cell Surface Glycoprotein CD3 Epsilon Chain Segment by Application
        • 1.3.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Comparison by Application (2014-2025)
        • 1.3.2 Autoimmune Disorders
        • 1.3.3 Hepatitis B
        • 1.3.4 Multiple Sclerosis
        • 1.3.5 Prostate Cancer
        • 1.3.6 Others
      • 1.3 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market by Region
        • 1.3.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size
        • 1.4.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2014-2025)
        • 1.4.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production (2014-2025)

      2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Competition by Manufacturers

      • 2.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers T Cell Surface Glycoprotein CD3 Epsilon Chain Production Sites, Area Served, Product Types
      • 2.5 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Competitive Situation and Trends
        • 2.5.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Concentration Rate
        • 2.5.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production Market Share by Regions

      • 3.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production Market Share by Regions
      • 3.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Regions (2014-2019)
      • 3.3 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Production
        • 3.4.1 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Production Growth Rate (2014-2019)
        • 3.4.2 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Production
        • 3.5.1 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Production Growth Rate (2014-2019)
        • 3.5.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China T Cell Surface Glycoprotein CD3 Epsilon Chain Production (2014-2019)
        • 3.6.1 China T Cell Surface Glycoprotein CD3 Epsilon Chain Production Growth Rate (2014-2019)
        • 3.6.2 China T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Production (2014-2019)
        • 3.7.1 Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Production Growth Rate (2014-2019)
        • 3.7.2 Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption by Regions

      • 4.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption by Regions
      • 4.2 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption (2014-2019)
      • 4.3 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption (2014-2019)
      • 4.4 China T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption (2014-2019)
      • 4.5 Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption (2014-2019)

      5 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price Trend by Type

      • 5.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production Market Share by Type (2014-2019)
      • 5.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Type (2014-2019)
      • 5.3 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Price by Type (2014-2019)
      • 5.4 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production Growth by Type (2014-2019)

      6 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Analysis by Applications

      • 6.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Market Share by Application (2014-2019)
      • 6.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in T Cell Surface Glycoprotein CD3 Epsilon Chain Business

      • 7.1 Amgen Inc
        • 7.1.1 Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Production Sites and Area Served
        • 7.1.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Product Introduction, Application and Specification
        • 7.1.3 Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Celgene Corp
        • 7.2.1 Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Production Sites and Area Served
        • 7.2.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Product Introduction, Application and Specification
        • 7.2.3 Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 F. Hoffmann-La Roche Ltd
        • 7.3.1 F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Production Sites and Area Served
        • 7.3.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Product Introduction, Application and Specification
        • 7.3.3 F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 GlaxoSmithKline Plc
        • 7.4.1 GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Production Sites and Area Served
        • 7.4.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Product Introduction, Application and Specification
        • 7.4.3 GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 MacroGenics Inc
        • 7.5.1 MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Production Sites and Area Served
        • 7.5.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Product Introduction, Application and Specification
        • 7.5.3 MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Meridigen Biotech Co Ltd
        • 7.6.1 Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Production Sites and Area Served
        • 7.6.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Product Introduction, Application and Specification
        • 7.6.3 Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Numab Innovation AG
        • 7.7.1 Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Production Sites and Area Served
        • 7.7.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Product Introduction, Application and Specification
        • 7.7.3 Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 SYNIMMUNE GmbH
        • 7.8.1 SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Production Sites and Area Served
        • 7.8.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Product Introduction, Application and Specification
        • 7.8.3 SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Tiziana Life Sciences Plc
        • 7.9.1 Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Production Sites and Area Served
        • 7.9.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Product Introduction, Application and Specification
        • 7.9.3 Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served

      8 T Cell Surface Glycoprotein CD3 Epsilon Chain Manufacturing Cost Analysis

      • 8.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of T Cell Surface Glycoprotein CD3 Epsilon Chain
      • 8.4 T Cell Surface Glycoprotein CD3 Epsilon Chain Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Distributors List
      • 9.3 T Cell Surface Glycoprotein CD3 Epsilon Chain Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Forecast

      • 11.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue Forecast
        • 11.1.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Price and Trend Forecast (2019-2025)
      • 11.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production Forecast by Regions (2019-2025)
        • 11.2.1 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue Forecast (2019-2025)
        • 11.2.3 China T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue Forecast (2019-2025)
      • 11.3 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast (2019-2025)
        • 11.3.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast (2019-2025)
        • 11.3.3 China T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast (2019-2025)
        • 11.3.4 Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast (2019-2025)
      • 11.4 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global T Cell Surface Glycoprotein CD3 Epsilon Chain market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on T Cell Surface Glycoprotein CD3 Epsilon Chain volume and value at global level, regional level and company level. From a global perspective, this report represents overall T Cell Surface Glycoprotein CD3 Epsilon Chain market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Amgen Inc
        Celgene Corp
        F. Hoffmann-La Roche Ltd
        GlaxoSmithKline Plc
        MacroGenics Inc
        Meridigen Biotech Co Ltd
        Numab Innovation AG
        SYNIMMUNE GmbH
        Tiziana Life Sciences Plc

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        ND-007
        Foralumab
        Coltelizumab
        AVA-002
        Others

        Segment by Application
        Autoimmune Disorders
        Hepatitis B
        Multiple Sclerosis
        Prostate Cancer
        Others

        Buy now